Dow Up 0.12% Nasdaq Up 1.35%

Advaxis, Inc. (ADXS)

-NasdaqCM
2.88 0.09(3.03%) Oct 20, 4:00PM EDT
Prev Close:2.97
Open:2.99
Bid:N/A
Ask:3.92 x 1500
1y Target Est:13.50
Beta:1.84
Next Earnings Date:N/A
Day's Range:2.77 - 2.99
52wk Range:2.46 - 5.99
Volume:124,114
Avg Vol (3m):251,715
Market Cap:56.21M
P/E (ttm):N/A
EPS (ttm):-1.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADXS

Comparison

Symbol% ChgMkt Cap
ADXSDown 3.03%56.21M
BVTIN/A
DNDN175.64M
VICL105.44M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):57.97
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Oct-14) :-1.16
Quarterly EPS Est (Oct-14) :-0.29
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Advaxis, Inc., a clinical development stage biotechnology company, focuses on developing immunotherapies for cancer and infectious diseases. The company’s Lm -LLO immunotherapy platform technology stimulates the immune system to induce antige... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback